Filing Details
- Accession Number:
- 0000950156-13-000021
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-15 10:52:05
- Reporting Period:
- 2013-01-02
- Filing Date:
- 2013-03-15
- Accepted Time:
- 2013-03-15 10:52:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
352998 | Igi Laboratories Inc | IG | Biological Products, (No Disgnostic Substances) (2836) | 010355758 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1184312 | C James Gale | Carnegie Hall Tower 152 West 57Th St. 19Th Fl. New York NY 10019 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-03-13 | 10,000 | $1.33 | 14,624 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Acquisiton | 2013-01-02 | 15,000 | $0.00 | 15,000 | $1.04 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
15,000 | 2014-01-02 | 2023-01-02 | No | 4 | A | Direct |
Footnotes
- These securities were granted as part of the Issuer's annual equity compensation to its non-employee directors under the Issuer's 1999 Director Stock Option Plan.